US Stock MarketDetailed Quotes

BMEZ Blackrock Health Sciences Trust II

Watchlist

15.590
-0.330-2.07%

Close Jul 18 16:00 ET

1.66BMarket Cap21.36P/E (TTM)

Blackrock Health Sciences Trust II Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Operating cash flow (Indirect Method)

Cash flow from continuing operating activities

Net income from continuing operations

110.23%69.86M

-137.18%-682.72M

-121.96%-287.85M

--1.31B

Change in working capital

344.93%9.83M

22.61%-4.01M

-139.95%-5.18M

--12.98M

-Change in receivables

-46.59%-343.6K

-77.77%-234.41K

79.53%-131.86K

---644.04K

-Change in prepaid assets

-133.41%-16.16K

271.81%48.37K

-39.26%-28.16K

---20.22K

-Change in other current assets

--0

-Change in other current liabilities

436.61%10.47M

32.92%-3.11M

-148.42%-4.64M

--9.58M

Cash from discontinued operating activities

Operating cash flow

-6.92%224.79M

27.32%241.5M

108.81%189.68M

---2.15B

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

Net issuance payments of debt

106.23%196.57K

146.39%95.31K

-200.00%-205.46K

--205.46K

Net commonstock issuance

-14.15%-51.04M

---44.71M

--0

--2.25B

Cash dividends paid

11.92%-173.52M

-3.37%-197M

-92.31%-190.59M

---99.1M

Net other financing activities

--0

Cash from discontinued financing activities

Financing cash flow

7.14%-224.37M

-26.64%-241.62M

-108.86%-190.79M

--2.15B

Net cash flow

Beginning cash position

-76.83%36.12K

-87.67%155.88K

1,164.01%1.26M

--100K

Current changes in cash

451.59%421.04K

89.19%-119.75K

-195.20%-1.11M

--1.16M

Effect of exchange rate changes

200.00%16

0.00%-16

-150.00%-16

--32

End cash position

1,165.87%457.17K

-76.83%36.12K

-87.67%155.88K

--1.26M

Free cash flow

-6.92%224.79M

27.32%241.5M

108.81%189.68M

---2.15B

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations	110.23%69.86M	-137.18%-682.72M	-121.96%-287.85M	--1.31B
Change in working capital	344.93%9.83M	22.61%-4.01M	-139.95%-5.18M	--12.98M
-Change in receivables	-46.59%-343.6K	-77.77%-234.41K	79.53%-131.86K	---644.04K
-Change in prepaid assets	-133.41%-16.16K	271.81%48.37K	-39.26%-28.16K	---20.22K
-Change in other current assets	--0	--0	--0	--0
-Change in other current liabilities	436.61%10.47M	32.92%-3.11M	-148.42%-4.64M	--9.58M
Cash from discontinued operating activities
Operating cash flow	-6.92%224.79M	27.32%241.5M	108.81%189.68M	---2.15B
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt	106.23%196.57K	146.39%95.31K	-200.00%-205.46K	--205.46K
Net commonstock issuance	-14.15%-51.04M	---44.71M	--0	--2.25B
Cash dividends paid	11.92%-173.52M	-3.37%-197M	-92.31%-190.59M	---99.1M
Net other financing activities	--0	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	7.14%-224.37M	-26.64%-241.62M	-108.86%-190.79M	--2.15B
Net cash flow
Beginning cash position	-76.83%36.12K	-87.67%155.88K	1,164.01%1.26M	--100K
Current changes in cash	451.59%421.04K	89.19%-119.75K	-195.20%-1.11M	--1.16M
Effect of exchange rate changes	200.00%16	0.00%-16	-150.00%-16	--32
End cash position	1,165.87%457.17K	-76.83%36.12K	-87.67%155.88K	--1.26M
Free cash flow	-6.92%224.79M	27.32%241.5M	108.81%189.68M	---2.15B
Currency Unit	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall